In a bid to further cement its position in the real estate industry, Polymath Real Estate Limited has launched Aura City Phase 2, themed ‘Powering Sustainable Dreams’. In a statement ...

Port Arthur LNG phase 2, which will consist of trains 3 and 4, is now permitted to export the equivalent of 698 billion cubic feet a year of gas, or about 13.5 million metric tons per annum (MMtpa ...

"These Phase 2 data for the combination of vilastobart and atezolizumab demonstrate a meaningfully differentiated safety and tolerability profile for an anti-CTLA-4 combination therapy, together with ...

GSK to pay $1.2 billion upfront and up to $800 million in milestones for efimosfermin, a Phase 3-ready liver disease drug. Efimosfermin showed fibrosis improvement, MASH resolution, and HbA1c ...

Team insiders Ryan Mink and Garrett Downing discuss some of the intriguing undrafted rookies who could make this year's 53-man roster. DeCosta & Harbaugh: Ravens 2025 NFL Draft Day 2 Press Conference ...

Presentation at ESMO will follow oral 2025 ASCO Annual Meeting presentation highlighting unprecedented survival data from Phase 2 OVATION 2 Study of IMNN-001 Simultaneously publication in leading ...

Abu Dhabi, UAE – MT Group today has announced the launch of Phase 2 of its supply chain expansion in Abu Dhabi, marking a significant milestone in the Emirate’s advanced manufacturing objectives.

A Phase 1b/2 trial in the U.S. will focus on monotherapy dose optimization, replacing the initial plan for a combination trial. Initial results from ongoing trials in China are anticipated in the ...

"Dosing the first patient in our Phase 2 CIDP trial marks an important step forward in our mission to deliver targeted, mechanism-based immunomodulation for patients with autoimmune diseases ...

The investigational combo of Vir’s monoclonal antibody tobevibart and Alnylam-discovered siRNA elebsiran was measured in a phase 2 trial for patients with chronic hepatitis B (CHB). Participants ...

The open-label, randomized, Phase 2 study will enroll approximately 50 patients with metastatic NSCLC whose tumors express PD-L1 and who have not previously received immune checkpoint inhibitors ...